Pioneer Group

ImmuONE specializes in inhalation toxicology, offering solutions for irritation sensitization, alveolar clearance, and inflammation. They provide human alveolar macrophage responses, epithelial cell culture platforms, and testing services, using advanced respiratory tissue models to deliver reliable results.

Neobe Therapeutics provides immunotherapies, clinical trials, research, and tumor-colonizing bacteria engineering services.

ImmuONE specializes in inhalation toxicology, offering solutions for irritation sensitization, alveolar clearance, and inflammation. They provide human alveolar macrophage responses, epithelial cell culture platforms, and testing services, using advanced respiratory tissue models to deliver reliable results.

Bastion Therapeutics is a preclinical biotechnology company developing proprietary platform technology to enhance regulatory T cells (Tregs) for immune system modulation.

NunaBio is a privately-owned specialist DNA development company based in England, United Kingdom. The company focuses on chemical and biological technologies, providing a diverse array of products and services, including long and short deoxyribonucleic acid products available in various scales, from microgram to gram. NunaBio is involved in contract research and development, as well as manufacturing, offering capabilities in cell therapies, vaccines, diagnostics, gene therapies, and advanced DNA biosensing. By delivering these innovative solutions, NunaBio aims to support healthcare professionals in their efforts to treat patients effectively.

Transdermal Diagnostics is a technology platform focused on the prevention, diagnosis, and management of chronic conditions, starting with diabetes. It offers a wearable system that provides needle-free, continuous glucose monitoring through affordable disposable patches, enabling people with diabetes and prediabetes to gain biological insights and make informed decisions for healthier living.